Literature DB >> 18996685

[Outcome of children with repaired oesophageal atresia].

F Gottrand1, R Sfeir, S Coopman, A Deschildre, L Michaud.   

Abstract

Although initial prognosis of oesophageal atresia is nowadays excellent with more than 95% of survival, the long-term complications are frequent. A gastro-oesophageal reflux is found in 26 to 75% of the cases, responsible for peptic oesophagitis, anastomotic stenosis and Barrett's oesophagus, risk factor of adenocarcinoma of the oesophagus. A dysphagia is frequently observed on these patients, sometimes several years after the surgery, observed in almost 45% of five-year-old children. Growth retardation is found in nearly a third of these children. Respiratory symptoms are particularly frequent, especially in the first years, associating tracheomalacia facilitating the bronchopulmonary infectious episodes (found in about 30% of 5-year-old children). Esotracheal fistula recurrence is very rare. A deformation of the rib cage is reported in 20%, and a scoliosis in 10% of the patients. However, the quality of life of these patients in the adulthood is good, and influenced by the existence of associated malformations. Even if the current prognosis of oesophageal atresia is good altogether, the frequency of the complications (digestive, respiratory, nutritional, orthopaedic) far from the initial intervention, and the necessity of a surveillance of the secondary oesophageal damages, justifies a systematic and multidisciplinary follow-up until adulthood.

Entities:  

Mesh:

Year:  2008        PMID: 18996685     DOI: 10.1016/j.arcped.2008.09.027

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  6 in total

Review 1.  Health-related quality of life among children, young people and adults with esophageal atresia: a review of the literature and recommendations for future research.

Authors:  Michaela Dellenmark-Blom; John Eric Chaplin; Vladimir Gatzinsky; Linus Jönsson; Kate Abrahamson
Journal:  Qual Life Res       Date:  2015-04-01       Impact factor: 4.147

2.  Changes in quality of life from infancy to school age after esophagoesophagostomy for tracheoesophageal fistula: thoracotomy versus thoracoscopy.

Authors:  Go Miyano; Shogo Seo; Hiroki Nakamura; Ryo Sueyoshi; Manabu Okawada; Takashi Doi; Hiroyuki Koga; Geoffrey J Lane; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2017-08-22       Impact factor: 1.827

3.  Dysphagia among adult patients who underwent surgery for esophageal atresia at birth.

Authors:  Valérie Huynh Trudeau; Stéphanie Maynard; Tatjana Terzic; Geneviève Soucy; Mickeal Bouin
Journal:  Can J Gastroenterol Hepatol       Date:  2015-03

4.  Agreement between mothers', fathers', and children's' ratings on health-related quality of life in children born with esophageal atresia - a German cross-sectional study.

Authors:  Stefanie Witt; Janika Bloemeke; Monika Bullinger; Jens Dingemann; Michaela Dellenmark-Blom; Julia Quitmann
Journal:  BMC Pediatr       Date:  2019-09-11       Impact factor: 2.125

5.  Laparoscopic fundoplication after oesophageal atresia repair.

Authors:  Maria-Grazia Scarpa; Daniela Codrich; Miriam Duci; Damiana Olenik; Jürgen Schleef
Journal:  Afr J Paediatr Surg       Date:  2022 Jul-Sep

6.  Results from the French National Esophageal Atresia register: one-year outcome.

Authors:  Anne Schneider; Sébastien Blanc; Arnaud Bonnard; Naziha Khen-Dunlop; Frédéric Auber; Anne Breton; Guillaume Podevin; Rony Sfeir; Virginie Fouquet; Catherine Jacquier; Jean-Louis Lemelle; Frédéric Lavrand; François Becmeur; Thierry Petit; Marie-Laurence Poli-Merol; Frédéric Elbaz; Thierry Merrot; Jean-Luc Michel; Allal Hossein; Manuel Lopez; Edouard Habonimana; Cécile Pelatan; Pascal De Lagausie; Philippe Buisson; Philine de Vries; Jean Gaudin; Hubert Lardy; Corine Borderon; Joséphine Borgnon; Olivier Jaby; Dominique Weil; Didier Aubert; Stephan Geiss; Jean Breaud; Anis Echaieb; Jane Languepin; Christophe Laplace; Myriam Pouzac; François Lefebvre; Frédéric Gottrand; Laurent Michaud
Journal:  Orphanet J Rare Dis       Date:  2014-12-11       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.